肝动脉化疗栓塞术联合脾部分栓塞术治疗原发性肝癌伴脾功能亢进的临床应用价值  

Clinical application value of hepatic arterial chemoembolization combined with partial splenic embolization in the treatment of primary liver cancer complicated with hypersplenism

作　　者：刘礼军[1] 涂年姣 余伟[1] Liu Lijun;Tu Nianjiao;Yu Wei(The People's Hospital of Hanchuan City,Hubei Province 431600)

机构地区：[1]湖北省汉川市人民医院,431600

出　　处：《中国社区医师》2017年第3期38-39,共2页Chinese Community Doctors

摘　　要：目的:探讨肝动脉化疗栓塞术联合脾部分栓塞术治疗原发性肝癌伴脾功能亢进的临床疗效。方法:收治原发性肝癌伴脾功能亢进患者62例,随机分为对照组和观察组,观察组采用肝动脉化疗栓塞术联合脾部分栓塞术治疗,对照组采用肝动脉化疗栓塞术治疗,比较两组治疗效果。结果:观察组肝功能改善情况明显优于对照组(P<0.05)。结论:肝动脉化疗栓塞术联合脾部分栓塞术治疗原发性肝癌伴脾功能亢进的临床疗效显著。Objective:To explore the clinical effect of hepatic arterial chemoembolization combined with partial splenic embolization in the treatment of primary liver cancer complicated with hypersplenism.Methods:62 patients with primary liver cancer complicated with hypersplenism were selected.They were randomly divided into the control group and the observation group.The observation group was treated with hepatic arterial chemoembolization combined with partial splenic embolization.The control group was treated with hepatic arterial chemoembolization.We compared the therapeutic effect of two groups.Results:The improvement of liver function in the observation group was significantly better than that in the control group(P<0.05).Conclusion:The clinical effect of hepatic arterial chemoembolization combined with partial splenic embolization in the treatment of primary liver cancer complicated with hypersplenism was significant.

关 键 词：肝动脉化疗栓塞术 脾部分栓塞术 肝癌 

分 类 号：R735.7[医药卫生—肿瘤]